Regulated necrosis: disease relevance and therapeutic opportunities (original) (raw)

• Laster, S. M., Wood, J. G. & Gooding, L. R. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J. Immunol. 141, 2629–2634 (1988).
  CAS PubMed Google Scholar
• Vanden Berghe, T., Linkermann, A., Jouan-Lanhouet, S., Walczak, H. & Vandenabeele, P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat. Rev. Mol. Cell Biol. 15, 135–147 (2014).
  Article CAS PubMed Google Scholar
• Green, D. R. & Levine, B. To be or not to be? How selective autophagy and cell death govern cell fate. Cell 157, 65–75 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Galluzzi, L., Pietrocola, F., Levine, B. & Kroemer, G. Metabolic control of autophagy. Cell 159, 1263–1276 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Brinkmann, V. & Zychlinsky, A. Neutrophil extracellular traps: is immunity the second function of chromatin? J. Cell Biol. 198, 773–783 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Lupfer, C., Malik, A. & Kanneganti, T. D. Inflammasome control of viral infection. Curr. Opin. Virol. 12, 38–46 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Mohammad, R. M. et al. Broad targeting of resistance to apoptosis in cancer. Semin. Cancer Biol. 35, S78–S103 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Vandenabeele, P., Galluzzi, L., Vanden Berghe, T. & Kroemer, G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 11, 700–714 (2010).
  Article CAS PubMed Google Scholar
• Sun, L. & Wang, X. A new kind of cell suicide: mechanisms and functions of programmed necrosis. Trends Biochem. Sci. 39, 587–593 (2014).
  Article CAS PubMed Google Scholar
• Degterev, A. et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1, 112–119 (2005).
  Article CAS PubMed Google Scholar
• Degterev, A. et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4, 313–321 (2008). References 10 and 11 describe the first series of small molecules able to prevent necrotic TNF-induced cell death via RIPK1 inhibition.
  Article CAS PubMed PubMed Central Google Scholar
• Pasparakis, M. & Vandenabeele, P. Necroptosis and its role in inflammation. Nature 517, 311–320 (2015).
  Article CAS PubMed Google Scholar
• Kim, S. K. et al. Upregulated RIP3 expression potentiates MLKL phosphorylation-mediated programmed necrosis in toxic epidermal necrolysis. J. Invest. Dermatol. 135, 2021–2030 (2015).
  Article CAS PubMed Google Scholar
• Ofengeim, D. et al. Activation of necroptosis in multiple sclerosis. Cell Rep. 10, 1836–1849 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Gunther, C. et al. Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature 477, 335–339 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Linkermann, A., Stockwell, B. R., Krautwald, S. & Anders, H. J. Regulated cell death and inflammation: an auto-amplification loop causes organ failure. Nat. Rev. Immunol. 14, 759–767 (2014).
  Article CAS PubMed Google Scholar
• He, S. et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α. Cell 137, 1100–1111 (2009).
  Article CAS PubMed Google Scholar
• Linkermann, A. et al. Dichotomy between RIP1- and RIP3-mediated necroptosis in tumor necrosis factor-α-induced shock. Mol. Med. 18, 577–586 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Newton, K. et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 343, 1357–1360 (2014).
  Article CAS PubMed Google Scholar
• Jouan-Lanhouet, S. et al. Necroptosis, in vivo detection in experimental disease models. Semin. Cell Dev. Biol. 35, 2–13 (2014).
  Article CAS PubMed Google Scholar
• Dondelinger, Y. et al. NF-κB-independent role of IKKα/IKKβ in preventing RIPK1 kinase-dependent apoptotic and necroptotic cell death during TNF signaling. Mol. Cell 60, 63–76 (2015).
  Article CAS PubMed Google Scholar
• Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181–190 (2003).
  Article CAS PubMed Google Scholar
• Wang, L., Du, F. & Wang, X. TNF-α induces two distinct caspase-8 activation pathways. Cell 133, 693–703 (2008).
  Article CAS PubMed Google Scholar
• Dondelinger, Y. et al. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition. Cell Death Differ. 20, 1381–1392 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Legarda-Addison, D., Hase, H., O'Donnell, M. A. & Ting, A. T. NEMO/IKKγ regulates an early NF-κB-independent cell-death checkpoint during TNF signaling. Cell Death Differ. 16, 1279–1288 (2009).
  Article CAS PubMed Google Scholar
• Oberst, A. et al. Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis. Nature 471, 363–367 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Cai, Z. et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat. Cell Biol. 16, 55–65 (2014).
  Article CAS PubMed Google Scholar
• Chen, X. et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res. 24, 105–121 (2014).
  Article CAS PubMed Google Scholar
• Dondelinger, Y. et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep. 7, 971–981 (2014).
  Article CAS PubMed Google Scholar
• Wang, H. et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol. Cell 54, 133–146 (2014).
  Article CAS PubMed Google Scholar
• Tenev, T. et al. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol. Cell 43, 432–448 (2011).
  Article CAS PubMed Google Scholar
• Feoktistova, M. et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 43, 449–463 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Mandal, P. et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol. Cell 56, 481–495 (2014). This paper demonstrates how small-molecule drugs targeting RIPK3 kinase activity indeed block necroptosis induction, but in some cases induce RIPK3-platform-mediated apoptosis involving caspase 8 and RIPK1 kinase activity.
  Article CAS PubMed PubMed Central Google Scholar
• Hildebrand, J. M. et al. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death. Proc. Natl Acad. Sci. USA 111, 15072–15077 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Teng, X. et al. Structure–activity relationship study of novel necroptosis inhibitors. Bioorg. Med. Chem. Lett. 15, 5039–5044 (2005).
  Article CAS PubMed Google Scholar
• Vandenabeele, P., Grootjans, S., Callewaert, N. & Takahashi, N. Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models. Cell Death Differ. 20, 185–187 (2013).
  Article CAS PubMed Google Scholar
• Takahashi, N. et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis. 3, e437 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Degterev, A., Maki, J. L. & Yuan, J. Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase. Cell Death Differ. 20, 366 (2013).
  Article CAS PubMed Google Scholar
• Prendergast, G. C., Chang, M. Y., Mandik-Nayak, L., Metz, R. & Muller, A. J. Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases. Curr. Med. Chem. 18, 2257–2262 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Xie, T. et al. Structural basis of RIP1 inhibition by necrostatins. Structure 21, 493–499 (2013).
  Article CAS PubMed Google Scholar
• Harris, P. A. et al. Discovery of small molecule RIP1 kinase inhibitors for the treatment of pathologies associated with necroptosis. ACS Med. Chem. Lett. 4, 1238–1243 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Najjar, M. et al. Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1. Cell Rep. 10, 1850–1860 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Fauster, A. et al. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis. Cell Death Dis. 6, e1767 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Newton, K., Sun, X. & Dixit, V. M. Kinase RIP3 is dispensable for normal NF-κBs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol. Cell. Biol. 24, 1464–1469 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Q. et al. Receptor-interacting protein kinase 3 contributes to abdominal aortic aneurysms via smooth muscle cell necrosis and inflammation. Circ. Res. 116, 600–611 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Kaiser, W. J. et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J. Biol. Chem. 288, 31268–31279 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Upton, J. W., Kaiser, W. J. & Mocarski, E. S. DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 11, 290–297 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Vitner, E. B. et al. RIPK3 as a potential therapeutic target for Gaucher's disease. Nat. Med. 20, 204–208 (2014).
  Article CAS PubMed Google Scholar
• Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213–227 (2012). In this paper, a pharmacoproteomics approach based on a necroptosis-inhibiting drug (NSA) led to the successful identification of the execution protein MLKL, which is regulated by RIPK3-dependent phosphorylation.
  Article CAS PubMed Google Scholar
• Li, J. et al. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150, 339–350 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Cauwels, A., Janssen, B., Waeytens, A., Cuvelier, C. & Brouckaert, P. Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat. Immunol. 4, 387–393 (2003).
  Article CAS PubMed Google Scholar
• Duprez, L. et al. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 35, 908–918 (2011).
  Article CAS PubMed Google Scholar
• Wu, J. et al. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res. 23, 994–1006 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Polykratis, A. et al. Cutting edge: RIPK1 kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo. J. Immunol. 193, 1539–1543 (2014).
  Article CAS PubMed Google Scholar
• Yang, W. S. & Stockwell, B. R. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem. Biol. 15, 234–245 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060–1072 (2012). In this paper, the term ferroptosis is coined, and it is shown that a functional system X c − is required to maintain glutathione levels to inhibit this form of cell death in a subset of cancer cell lines.
  Article CAS PubMed PubMed Central Google Scholar
• Sato, H., Tamba, M., Ishii, T. & Bannai, S. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 274, 11455–11458 (1999).
  Article CAS PubMed Google Scholar
• Conrad, M. & Sato, H. The oxidative stress-inducible cystine/glutamate antiporter, system Xc−: cystine supplier and beyond. Amino Acids 42, 231–246 (2012).
  Article CAS PubMed Google Scholar
• Ursini, F., Maiorino, M., Valente, M., Ferri, L. & Gregolin, C. Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Biochim. Biophys. Acta 710, 197–211 (1982).
  Article CAS PubMed Google Scholar
• Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317–331 (2014). This paper shows that GPX4 is the limiting glutathione-utilizing enzyme required for the prevention of ferroptosis in cancer cells.
  Article CAS PubMed PubMed Central Google Scholar
• Friedmann Angeli, J. P. et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180–1191 (2014). This paper shows that the ferroptosis inhibitor liproxstatin-1 protects mice from acute renal failure induced by inducible Gpx4 ablation as well as from hepatic IRI.
  Article CAS PubMed Google Scholar
• Linkermann, A. et al. Synchronized renal tubular cell death involves ferroptosis. Proc. Natl Acad. Sci. USA 111, 16836–16841 (2014). This paper indicates that in vivo inhibition of ferroptosis leads to a protective effect in a pathophysiological setting, such as IRI in the kidney.
  Article CAS PubMed PubMed Central Google Scholar
• Seiler, A. et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell. Metab. 8, 237–248 (2008). This paper describes the first conditional-knockout model of the ferroptosis regulator GPX4 in cells and mice, which were further used for the development of liproxstatin-1 and for assessing the importance of ferroptosis in different tissues.
  Article CAS PubMed Google Scholar
• Yoo, S. E. et al. Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain. Free Radic. Biol. Med. 52, 1820–1827 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, L., Na, R., Gu, M., Richardson, A. & Ran, Q. Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer's disease. J. Neurochem. 107, 197–207 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Yoo, M. H. et al. Delineating the role of glutathione peroxidase 4 in protecting cells against lipid hydroperoxide damage and in Alzheimer's disease. Antioxid. Redox Signal 12, 819–827 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ufer, C. et al. Translational regulation of glutathione peroxidase 4 expression through guanine-rich sequence-binding factor 1 is essential for embryonic brain development. Genes Dev. 22, 1838–1850 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Hauser, D. N., Dukes, A. A., Mortimer, A. D. & Hastings, T. G. Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4. Free Radic. Biol. Med. 65, 419–427 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Bellinger, F. P. et al. Changes in selenoprotein P in substantia nigra and putamen in Parkinson's disease. J. Parkinsons Dis. 2, 115–126 (2012).
  CAS PubMed PubMed Central Google Scholar
• Bellinger, F. P. et al. Glutathione peroxidase 4 is associated with neuromelanin in substantia nigra and dystrophic axons in putamen of Parkinson's brain. Mol. Neurodegener. 6, 8 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Skouta, R. et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J. Am. Chem. Soc. 136, 4551–4556 (2014). Ferrostatins with improved properties are reported in this paper to be effective in several cellular disease models. These ferrostatins block lipid peroxidation, but not by inhibiting mitochondrial ROS production or preventing lysosomal membrane permeabilization.
  Article CAS PubMed PubMed Central Google Scholar
• Wirth, E. K. et al. Cerebellar hypoplasia in mice lacking selenoprotein biosynthesis in neurons. Biol. Trace Elem. Res. 158, 203–210 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Roth, T. L. et al. Transcranial amelioration of inflammation and cell death after brain injury. Nature 505, 223–228 (2014).
  Article CAS PubMed Google Scholar
• Korade, Z. et al. Antioxidant supplementation ameliorates molecular deficits in Smith–Lemli–Opitz syndrome. Biol. Psychiatry 75, 215–222 (2014).
  Article CAS PubMed Google Scholar
• Ueta, T. et al. Glutathione peroxidase 4 is required for maturation of photoreceptor cells. J. Biol. Chem. 287, 7675–7682 (2012).
  Article CAS PubMed Google Scholar
• Sengupta, A. et al. Targeted disruption of glutathione peroxidase 4 in mouse skin epithelial cells impairs postnatal hair follicle morphogenesis that is partially rescued through inhibition of COX-2. J. Invest. Dermatol. 133, 1731–1741 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Matsushita, M. et al. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J. Exp. Med. 212, 555–568 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Wortmann, M. et al. Combined deficiency in glutathione peroxidase 4 and vitamin E causes multiorgan thrombus formation and early death in mice. Circ. Res. 113, 408–417 (2013).
  Article CAS PubMed Google Scholar
• Woo, J. H. et al. Elucidating compound mechanism of action by network perturbation analysis. Cell 162, 441–451 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Bannai, S. Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J. Biol. Chem. 261, 2256–2263 (1986).
  CAS PubMed Google Scholar
• Mandal, P. K. et al. System Xc− and thioredoxin reductase 1 cooperatively rescue glutathione deficiency. J. Biol. Chem. 285, 22244–22253 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Jiang, L. et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520, 57–62 (2015). This paper implicates ferroptosis as a non-canonical tumour suppressive function of p53 via p53-mediated transcriptional inhibition of system X c −.
  Article CAS PubMed PubMed Central Google Scholar
• Hayano, M., Yang, W. S., Corn, C. K., Pagano, N. C. & Stockwell, B. R. Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation. Cell Death Differ. http://dx.doi.org/10.1038/cdd.2015.93 (2015).
• Yant, L. J. et al. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radic. Biol. Med. 34, 496–502 (2003).
  Article CAS PubMed Google Scholar
• Gao, M., Monian, P., Quadri, N., Ramasamy, R. & Jiang, X. Glutaminolysis and transferrin regulate ferroptosis. Mol. Cell 59, 298–308 (2015). This paper suggests that inhibiting glutaminolysis might be a putative anti-ferroptotic pharmacological approach and that cells that preferably use glutaminolysis for energy production are more sensitive to ferroptosis.
  Article CAS PubMed PubMed Central Google Scholar
• Tretter, L. & Adam-Vizi, V. Generation of reactive oxygen species in the reaction catalyzed by α-ketoglutarate dehydrogenase. J. Neurosci. 24, 7771–7778 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Bae, Y. S. et al. Platelet-derived growth factor-induced H2O2 production requires the activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 275, 10527–10531 (2000).
  Article CAS PubMed Google Scholar
• Han, C. Y. et al. NADPH oxidase-derived reactive oxygen species increases expression of monocyte chemotactic factor genes in cultured adipocytes. J. Biol. Chem. 287, 10379–10393 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Li, B. et al. Fructose-1,6-bisphosphatase opposes renal carcinoma progression. Nature 513, 251–255 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Dixon, S. J. et al. Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem. Biol. 10, 1604–1609 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Dixon, S. J. et al. Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis. eLife 3, e02523 (2014). Here, inhibition of system X c − by erastin or sorafenib is shown to be associated with endoplasmic reticulum stress and glutathione- specific γ-glutamylcyclotransferase 1 upregulation involved in glutathione degradation.
  Article PubMed PubMed Central Google Scholar
• Yagoda, N. et al. RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447, 864–868 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Louandre, C. et al. Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib. Int. J. Cancer 133, 1732–1742 (2013).
  Article CAS PubMed Google Scholar
• Chung, W. J. et al. Inhibition of cystine uptake disrupts the growth of primary brain tumors. J. Neurosci. 25, 7101–7110 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, R. S. et al. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/β-catenin pathway. Oncogene 28, 599–609 (2009).
  Article CAS PubMed Google Scholar
• Nagano, O., Okazaki, S. & Saya, H. Redox regulation in stem-like cancer cells by CD44 variant isoforms. Oncogene 32, 5191–5198 (2013).
  Article CAS PubMed Google Scholar
• Timmerman, L. A. et al. Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell 24, 450–465 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Keldsen, N., Havsteen, H., Vergote, I., Bertelsen, K. & Jakobsen, A. Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study. Gynecol. Oncol. 88, 118–122 (2003).
  Article CAS PubMed Google Scholar
• Lee, Y. et al. Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss. Nat. Neurosci. 16, 1392–1400 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Virag, L., Robaszkiewicz, A., Rodriguez-Vargas, J. M. & Oliver, F. J. Poly(ADP-ribose) signaling in cell death. Mol. Aspects Med. 34, 1153–1167 (2013).
  Article CAS PubMed Google Scholar
• Curtin, N. J. & Szabo, C. Therapeutic applications of PARP inhibitors: anticancer therapy and beyond. Mol. Aspects Med. 34, 1217–1256 (2013).
  Article CAS PubMed Google Scholar
• Mashimo, M., Kato, J. & Moss, J. ADP-ribosyl-acceptor hydrolase 3 regulates poly (ADP-ribose) degradation and cell death during oxidative stress. Proc. Natl Acad. Sci. USA 110, 18964–18969 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Andrabi, S. A., Dawson, T. M. & Dawson, V. L. Mitochondrial and nuclear cross talk in cell death: parthanatos. Ann. NY Acad. Sci. 1147, 233–241 (2008).
  Article CAS PubMed Google Scholar
• Wang, Y. et al. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos). Sci. Signal. 4, ra20 (2011).
  PubMed PubMed Central Google Scholar
• Andrabi, S. A. et al. Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death. Nat. Med. 17, 692–699 (2011). In this paper, the first endogenous inhibitor of parthanatos is described, indicating that interfering with PAR polymer signalling is a putative treatment for neurodegenerative disease.
  Article CAS PubMed PubMed Central Google Scholar
• Graziani, G. & Szabo, C. Clinical perspectives of PARP inhibitors. Pharmacol. Res. 52, 109–118 (2005).
  Article CAS PubMed Google Scholar
• del Moral, R. M. et al. PARP inhibition attenuates histopathological lesion in ischemia/reperfusion renal mouse model after cold prolonged ischemia. ScientificWorldJournal 2013, 486574 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Sahaboglu, A. et al. PARP1 gene knock-out increases resistance to retinal degeneration without affecting retinal function. PLoS ONE 5, e15495 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Jagtap, P. et al. Novel phenanthridinone inhibitors of poly (adenosine 5′-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit. Care Med. 30, 1071–1082 (2002).
  Article CAS PubMed Google Scholar
• Jagtap, P. G. et al. The discovery and synthesis of novel adenosine substituted 2,3-dihydro-1_H_-isoindol-1-ones: potent inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1). Bioorg. Med. Chem. Lett. 14, 81–85 (2004).
  Article CAS PubMed Google Scholar
• Jagtap, P. G. et al. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J. Med. Chem. 48, 5100–5103 (2005).
  Article CAS PubMed Google Scholar
• Morrow, D. A. et al. A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial. J. Thromb. Thrombolysis 27, 359–364 (2009).
  Article CAS PubMed Google Scholar
• US National Library of Medicine. ClinicalTrials.gov [online], (2013).
• Andrabi, S. A. et al. Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis. Proc. Natl Acad. Sci. USA 111, 10209–10214 (2014). Although parthanatos still lacks a clear core cell death pathway, this paper indicates that overactivation of PARP1 is caused by PAR-dependent inhibition of glycolysis through the inhibition of HK, explaining the bioenergetic collapse that results in necrotic cell death.
  Article CAS PubMed PubMed Central Google Scholar
• Devalaraja-Narashimha, K., Diener, A. M. & Padanilam, B. J. Cyclophilin D gene ablation protects mice from ischemic renal injury. Am. J. Physiol. Renal Physiol. 297, F749–F759 (2009).
  Article CAS PubMed Google Scholar
• Millay, D. P. et al. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat. Med. 14, 442–447 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Jobe, S. M. et al. Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis. Blood 111, 1257–1265 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Fujimoto, K., Chen, Y., Polonsky, K. S. & Dorn, G. W. 2nd. Targeting cyclophilin D and the mitochondrial permeability transition enhances β-cell survival and prevents diabetes in Pdx1 deficiency. Proc. Natl Acad. Sci. USA 107, 10214–10219 (2010).
  Article PubMed PubMed Central Google Scholar
• Forte, M. et al. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Proc. Natl Acad. Sci. USA 104, 7558–7563 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Javadov, S. & Kuznetsov, A. Mitochondrial permeability transition and cell death: the role of cyclophilin D. Front. Physiol. 4, 76 (2013).
  CAS PubMed PubMed Central Google Scholar
• Giorgio, V. et al. Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc. Natl Acad. Sci. USA 110, 5887–5892 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Bonora, M., Bravo- San Pedro, J. M., Kroemer, G., Galluzzi, L. & Pinton, P. Novel insights into the mitochondrial permeability transition. Cell Cycle 13, 2666–2670 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Green, D. R., Galluzzi, L. & Kroemer, G. Cell biology. Metabolic control of cell death. Science 345, 1250256 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Vaseva, A. V. et al. p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 149, 1536–1548 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Karch, J. & Molkentin, J. D. Is p53 the long-sought molecular trigger for cyclophilin D-regulated mitochondrial permeability transition pore formation and necrosis? Circ. Res. 111, 1258–1260 (2012).
  Article CAS PubMed Google Scholar
• Nakagawa, T. et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434, 652–658 (2005).
  Article CAS PubMed Google Scholar
• Baines, C. P. et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658–662 (2005).
  Article CAS PubMed Google Scholar
• Schinzel, A. C. et al. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc. Natl Acad. Sci. USA 102, 12005–12010 (2005). References 126–128 characterize the requirement of CypD for the formation of the MPTP, and its inhibition as a pharmacologically amenable approach.
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, L. H., Youn, H. D. & Liu, J. O. Inhibition of cell cycle progression by the novel cyclophilin ligand sanglifehrin A is mediated through the NFκB-dependent activation of p53. J. Biol. Chem. 276, 43534–43540 (2001).
  Article CAS PubMed Google Scholar
• Clarke, S. J., McStay, G. P. & Halestrap, A. P. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. J. Biol. Chem. 277, 34793–34799 (2002).
  Article CAS PubMed Google Scholar
• Linkermann, A. et al. Two independent pathways of regulated necrosis mediate ischemia–reperfusion injury. Proc. Natl Acad. Sci. USA 110, 12024–12029 (2013).
  Article PubMed PubMed Central Google Scholar
• Nighoghossian, N. et al. Cyclosporine in acute ischemic stroke. Neurology 84, 2216–2223 (2015).
  Article CAS PubMed Google Scholar
• Keogh, A. Calcineurin inhibitors in heart transplantation. J. Heart Lung Transplant 23, S202–S206 (2004).
  Article PubMed Google Scholar
• Zhao, H. et al. Necroptosis and parthanatos are involved in remote lung injury after receiving ischemic renal allografts in rats. Kidney Int. 87, 738–748 (2015).
  Article CAS PubMed Google Scholar
• Takahashi, N. et al. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Nature 513, 95–99 (2014).
  Article CAS PubMed Google Scholar
• Dannappel, M. et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513, 90–94 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Lamkanfi, M. & Dixit, V. M. Mechanisms and functions of inflammasomes. Cell 157, 1013–1022 (2014).
  Article CAS PubMed Google Scholar
• Bergsbaken, T., Fink, S. L. & Cookson, B. T. Pyroptosis: host cell death and inflammation. Nat. Rev. Microbiol. 7, 99–109 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ch'en, I. L., Tsau, J. S., Molkentin, J. D., Komatsu, M. & Hedrick, S. M. Mechanisms of necroptosis in T cells. J. Exp. Med. 208, 633–641 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Moriwaki, K. & Chan, F. K. Necrosis-dependent and independent signaling of the RIP kinases in inflammation. Cytokine Growth Factor Rev. 25, 167–174 (2014).
  Article CAS PubMed Google Scholar
• Munoz-Planillo, R. et al. K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38, 1142–1153 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Misawa, T. et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat. Immunol. 14, 454–460 (2013).
  Article CAS PubMed Google Scholar
• Zhou, R., Yazdi, A. S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221–225 (2011).
  Article CAS PubMed Google Scholar
• Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847–856 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Upton, J. W., Kaiser, W. J. & Mocarski, E. S. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7, 302–313 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kang, T. B., Yang, S. H., Toth, B., Kovalenko, A. & Wallach, D. Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity 38, 27–40 (2013). This study puts forward for the first time the possible and complex interaction between the necrosome and inflammasome machinery.
  Article CAS PubMed Google Scholar
• Moriwaki, K., Bertin, J., Gough, P. J. & Chan, F. K. A. RIPK3-caspase 8 complex mediates atypical pro-IL-1β processing. J. Immunol. 194, 1938–1944 (2015).
  Article CAS PubMed Google Scholar
• Lawlor, K. E. et al. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat. Commun. 6, 6282 (2015).
  Article CAS PubMed Google Scholar
• Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signaling. 526, 666–671 Nature (2015).
  Article CAS PubMed Google Scholar
• Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. 526, 660–665 Nature (2015).
  Article CAS PubMed Google Scholar
• Coll, R. C. et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21, 248–255 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Tan, S., Schubert, D. & Maher, P. Oxytosis: a novel form of programmed cell death. Curr. Top. Med. Chem. 1, 497–506 (2001).
  Article CAS PubMed Google Scholar
• Li, Y., Maher, P. & Schubert, D. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19, 453–463 (1997).
  Article CAS PubMed Google Scholar
• Pallast, S. et al. Increased nuclear apoptosis-inducing factor after transient focal ischemia: a 12/15-lipoxygenase-dependent organelle damage pathway. J. Cereb. Blood Flow Metab. 30, 1157–1167 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Pallast, S., Arai, K., Wang, X., Lo, E. H. & van Leyen, K. 12/15-lipoxygenase targets neuronal mitochondria under oxidative stress. J. Neurochem. 111, 882–889 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Yigitkanli, K. et al. Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke. Ann. Neurol. 73, 129–135 (2013).
  Article CAS PubMed Google Scholar
• van Leyen, K. et al. Baicalein and 12/15-lipoxygenase in the ischemic brain. Stroke 37, 3014–3018 (2006). This study demonstrates that glutathione depletion leads to lipid peroxidation and cell death in neuronal cells — a phenomenon later termed as oxytosis, which is related to ferroptosis.
  Article CAS PubMed Google Scholar
• Jin, G. et al. Protecting against cerebrovascular injury: contributions of 12/15-lipoxygenase to edema formation after transient focal ischemia. Stroke 39, 2538–2543 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Oxler, E. M., Dolga, A. & Culmsee, C. AIF depletion provides neuroprotection through a preconditioning effect. Apoptosis 17, 1027–1038 (2012).
  Article CAS PubMed Google Scholar
• Mahoney, D. J. et al. Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activation. Proc. Natl Acad. Sci. USA 105, 11778–11783 (2008).
  Article PubMed PubMed Central Google Scholar
• Haas, T. L. et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831–844 (2009).
  Article CAS PubMed Google Scholar
• Varfolomeev, E. et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 131, 669–681 (2007).
  Article CAS PubMed Google Scholar
• Vince, J. E. et al. IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis. Cell 131, 682–693 (2007).
  Article CAS PubMed Google Scholar
• Petersen, S. L. et al. Autocrine TNFα signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 12, 445–456 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Bertrand, M. J. et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30, 689–700 (2008).
  Article CAS PubMed Google Scholar
• Lin, Y., Devin, A., Rodriguez, Y. & Liu, Z. G. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 13, 2514–2526 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Feng, S. et al. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signal 19, 2056–2067 (2007).
  Article CAS PubMed Google Scholar
• O'Donnell, M. A. et al. Caspase 8 inhibits programmed necrosis by processing CYLD. Nat. Cell Biol. 13, 1437–1442 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Cho, Y. S. et al. Phosphorylation-driven assembly of the RIP1–RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112–1123 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, D. W. et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332–336 (2009).
  Article CAS PubMed Google Scholar
• Zhao, J. et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc. Natl Acad. Sci. USA 109, 5322–5327 (2012).
  Article PubMed PubMed Central Google Scholar
• Fulda, S. Smac mimetics as IAP antagonists. Semin. Cell Dev. Biol. 39, 132–138 (2015).
  Article CAS PubMed Google Scholar
• Kobayashi, S. et al. Cystathionine is a novel substrate of cystine/glutamate transporter: implications for immune function. J. Biol. Chem. 290, 8778–8788 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Bannai, S. & Kitamura, E. Transport interaction of l-cystine and l-glutamate in human diploid fibroblasts in culture. J. Biol. Chem. 255, 2372–2376 (1980).
  CAS PubMed Google Scholar
• Gout, P. W., Buckley, A. R., Simms, C. R. & Bruchovsky, N. Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the Xc− cystine transporter: a new action for an old drug. Leukemia 15, 1633–1640 (2001).
  Article CAS PubMed Google Scholar
• Patel, S. A., Warren, B. A., Rhoderick, J. F. & Bridges, R. J. Differentiation of substrate and non-substrate inhibitors of transport system Xc−: an obligate exchanger of l -glutamate and l-cystine. Neuropharmacology 46, 273–284 (2004).
  Article CAS PubMed Google Scholar
• Fatokun, A. A., Dawson, V. L. & Dawson, T. M. Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities. Br. J. Pharmacol. 171, 2000–2016 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Shall, S. Proceedings: experimental manipulation of the specific activity of poly(ADP-ribose) polymerase. J. Biochem 77, 2p (1975).
  Article CAS PubMed Google Scholar
• Fatokun, A. A., Liu, J. O., Dawson, V. L. & Dawson, T. M. Identification through high-throughput screening of 4′-methoxyflavone and 3′,4′-dimethoxyflavone as novel neuroprotective inhibitors of parthanatos. Br. J. Pharmacol. 169, 1263–1278 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Greco, R. et al. Neuroprotection by the PARP inhibitor PJ34 modulates cerebral and circulating RAGE levels in rats exposed to focal brain ischemia. Eur. J. Pharmacol. 744, 91–97 (2014).
  Article CAS PubMed Google Scholar
• Wang, J. et al. Inhibition of poly (ADP-ribose) polymerase and inducible nitric oxide synthase protects against ischemic myocardial damage by reduction of apoptosis. Mol. Med. Rep. 11, 1768–1776 (2015).
  Article CAS PubMed Google Scholar
• Ha, H. C. & Snyder, S. H. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Natl Acad. Sci. USA 96, 13978–13982 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Meier, H. L., Ballough, G. P., Forster, J. S. & Filbert, M. G. Benzamide, a poly(ADP-ribose) polymerase inhibitor, is neuroprotective against soman-induced seizure-related brain damage. Ann. NY Acad. Sci. 890, 330–335 (1999).
  Article CAS PubMed Google Scholar
• Purnell, M. R. & Whish, W. J. Novel inhibitors of poly(ADP-ribose) synthetase. Biochem. J. 185, 775–777 (1980).
  Article CAS PubMed PubMed Central Google Scholar
• Szabo, G. et al. INO-1001 a novel poly(ADP-ribose) polymerase (PARP) inhibitor improves cardiac and pulmonary function after crystalloid cardioplegia and extracorporal circulation. Shock 21, 426–432 (2004).
  Article CAS PubMed Google Scholar
• d'Avila, J. C. et al. Microglial activation induced by brain trauma is suppressed by post-injury treatment with a PARP inhibitor. J. Neuroinflamm. 9, 31 (2012).
  CAS Google Scholar
• US National Library of Medicine. ClinicalTrials.gov [online], (2006).
• US National Library of Medicine. ClinicalTrials.gov [online], (2005).
• van Leyen, K. et al. Novel lipoxygenase inhibitors as neuroprotective reagents. J. Neurosci. Res. 86, 904–909 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Niki, E. & Traber, M. G. A history of vitamin E. Ann. Nutr. Metab. 61, 207–212 (2012).
  Article CAS PubMed Google Scholar
• Griffith, O. W. Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J. Biol. Chem. 257, 13704–13712 (1982).
  CAS PubMed Google Scholar
• Harris, I. S. et al. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 27, 211–222 (2015).
  Article CAS PubMed Google Scholar
• Kim, S. Y. et al. Inhibition of cyclophilin D by cyclosporin A promotes retinal ganglion cell survival by preventing mitochondrial alteration in ischemic injury. Cell Death Dis. 5, e1105 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Teixeira, G. et al. Synergistic protective effect of cyclosporin A and rotenone against hypoxia–reoxygenation in cardiomyocytes. J. Mol. Cell Cardiol. 56, 55–62 (2013).
  Article CAS PubMed Google Scholar
• Wang, X. et al. Developmental shift of cyclophilin D contribution to hypoxic-ischemic brain injury. J. Neurosci. 29, 2588–2596 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Hausenloy, D., Wynne, A., Duchen, M. & Yellon, D. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation 109, 1714–1717 (2004).
  Article CAS PubMed Google Scholar
• Strom, E. et al. Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat. Chem. Biol. 2, 474–479 (2006).
  Article CAS PubMed Google Scholar